Latest News

Publications

mBio-2020-Morrissette-e02310-20.full_

January 1, 1970

A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

Madeleine Morrissette, Norman Pitt, Antonio González, Philip Strandwitz, Mariaelena Caboni, Alison W. Rebman, Rob Knight, Anthony D’Onofrio, John N. Aucott, Mark J. Soloski, Kim Lewis
s41598-020-59600-4

March 2, 2020

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31

Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati, Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed, and Jayakumar Rajadas
liegner

May 30, 2019

Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases

By Kenneth Liegner
shor

December 16, 2019

Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group

By Samuel Shor, Christine Green, Beatrice Szantyr, Steven Philips, Kenneth Liegner, Joseph Burrascano Jr., Robert Bransfield, Elizabeth L. Maloney
barth

November 16, 2009

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi

By Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ
nocton

January 27, 1994

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis

By Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC
01-15-2021

Does Bartonella Contribute to the Occurrence of Cutaneous Lesions and Neuropsychiatric Symptoms in Patients?

01-12-2021

New Estimates of People Diagnosed/Treated for Lyme: 476,000 Annually

12-31-2020

Help Us Help You – Last Chance to Donate in 2020

12-28-2020

Success in 2020: Help LDA Work for You in the New Year!

12-28-2020

Success in 2020/IDSA Guidelines/Pat Smith Last WG Remarks/Disulfiram/Attempt to Save a Lyme/COVID Patient/Lyme Pathogenesis/COVID

12-23-2020

Lyme Disease Pathogenesis- A Review